EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

STUDIES OF HEART & KIDNEY PROTECTION WITH BI 690517 IN COMBINATION WITH EMPAGLIFLOZIN: A MULTICENTER, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF THE ALDOSTERONE SYNTHASE INHIBITOR BI 690517 IN COMBINATION WITH EMPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Intervention/treatment:
VICADROSTAT (BI 690517) / EMPAGLIFLOZIN
Medical condition:
CHRONIC KIDNEY DISEASE (CKD)
Protocol code:
1378-0006
Control number:
286756
Status:
Recruiting
Approved:
June 06, 2024
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT06531824
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
1-800-243-0127
Sponsor
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Locations

Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, H2X 0A9
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
CHU de Quebec-Universite Laval Research Centre
Québec, G1R 2J6
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Diex Recherche Québec
Québec, G1V 4T3
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346

Alberta

University of Alberta Hospital (University of Alberta)
Edmonton, Alberta, T6G 2P4
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346

British Columbia

Fraser Health
Surrey, British Columbia, V3W 1J8
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Kelowna General Hospital
Kelowna, British Columbia, V1Y 1T2
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Northern Health
Prince George, British Columbia, V2M 1S2
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Royal Inland Hospital
Kamloops, British Columbia, V2C 2T1
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
St. Paul's Hospital (Vancouver)
Vancouver, British Columbia, V1Y 1S1
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346

Nova Scotia

Centre for Clinical Research
Halifax, Nova Scotia, B3H 1V7
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346

Ontario

Centricity Research (Brampton)
Brampton, Ontario, L6S 0C6
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Centricity Research (Vaughan)
Concord, Ontario, L4K 4M2
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Lakeridge Health Oshawa
Oshawa, Ontario, L1G 2B9
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
London Regional Cancer Program - London Health Sciences Ctr.
London, Ontario, N6A 5W9
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Queen's University
Kingston, Ontario, K7L 3N6
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
St. Michael's Hospital
Toronto, Ontario, M5C2T2
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4G 3E8
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
The Ottawa Hospital
Ottawa, Ontario, K1H 7W9
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Toronto General Hospital
Toronto, Ontario, M5G 2N2
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346

Quebec

CIUSSS de l'Est-de-l'Île-de-Montréal
Montreal, Quebec, H1T 2M4
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
CIUSSS de l Estrie-CHUS
Sherbrooke, Quebec, J1H 5N4
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
CIUSSS Nord de l'île de Montreal
Québec, Quebec, H4J 1C5
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
McGill University Health Centre (MUHC)
Montreal, Quebec, H3G 1A4
Recruiting
Name
Boehringer Ingelheim
Role
CONTACT
Phone:
18336022346
Did you find what you were looking for?

Contacts and resources